CD8A and COVID-19: With respect to adaptive immunity, a consistent finding is the low number of CD4+ and CD8 + T cells, particularly in patients with severe clinical presentations and outcomes.10–14 Moreover, T cell exhaustion and skewing toward TH17 has been observed in COVID-19 patients.12